We are live on
!
Find out more
DMTX
Dimension Therapeutics, Inc
DMTX
DMTX
Delisted
DMTX was delisted on the 6th of November, 2017.
54 hedge funds and large institutions have $170M invested in Dimension Therapeutics, Inc in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
32% more capital invested
Capital invested by funds: $129M → $170M (+$41.3M)
4% more funds holding
Funds holding: 52 → 54 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
6
Increased
17
Reduced
17
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.59M |
| 2 |
JP Morgan Chase
New York
|
-$749K |
| 3 |
Goldman Sachs
New York
|
-$548K |
| 4 |
AG
Artal Group
Luxembourg
|
-$293K |
| 5 |
SIM
Spark Investment Management
New York
|
-$169K |
